|
|
||||||||
The Annals of Thoracic Surgery, Vol 55, 283-287, Copyright © 1993 by The Society of Thoracic Surgeons
S Lick, JG Copeland 3d, RG Smith, M Cleavinger, LJ Rosado, CL Huston, GK Sethi and TF Molloy
From 1988 to 1991 13 patients received Symbion biventricular assist devices
in attempts to bridge them to cardiac transplantation. All 7 of those who
had cardiac transplants survived to hospital discharge. One death occurred
60 days after transplantation because of rejection. All other patients who
received transplants are surviving. Implant times in this group varied from
10 to 164 days (mean, 55 days). There were two embolic neurologic events
and two significant infections, and 2 of the survivors were dialyzed for
reversible renal failure before transplantation. Of those who died on
device support, 3 presented on centrifugal pump support. The three other
deaths were caused by graft rejection, multiple organ failure, and multiple
peripheral emboli. Biventricular assist devices optimally provide cardiac
outputs of 4 to 5 L/min, can be quickly inserted often without requiring
cardiopulmonary bypass, are easily explanted, and seem best suited for
patients weighing less than 80 kg.
ARTICLES
Use of the Symbion biventricular assist device in bridging to transplantation
University of Arizona Health Science Center, Tucson 85715.
This article has been cited by other articles:
![]() |
J. G. Copeland III, F. A. Arabia, M. E. Banchy, G. K. Sethi, B. Foy, J. Long, R. L. Kormos, and R. G. Smith The CardioWest total artificial heart bridge to transplantation: 1993 to 1996 National Trial Ann. Thorac. Surg., November 1, 1998; 66(5): 1662 - 1669. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |